Company intelligence / Profile preview

Huatai International

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Huatai International is the international business platform of Huatai Securities, operating primarily from Hong Kong and the United States to provide cross-border financial services. Its activities include investment banking, securities trading, wealth management, asset management, and related offshore capital markets services. The company appears to be a wholly owned subsidiary of Huatai Securities and is focused on capital markets and financial intermediation rather than biotechnology, pharmaceuticals, or healthcare operations. Based on the available evidence, it is not a life sciences company and does not maintain a therapeutic pipeline.

Industry: Investors

Beyond the preview

Go deeper on Huatai International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huatai International.

Explore the full profile